Published in Helicobacter on August 01, 2006
Rescue Therapy for Helicobacter pylori Infection 2012. Gastroenterol Res Pract (2012) 1.10
Quinolone resistance in Helicobacter pylori isolates in Germany. Antimicrob Agents Chemother (2006) 1.07
Should quinolones come first in Helicobacter pylori therapy? Therap Adv Gastroenterol (2011) 1.01
"Rescue" regimens after Helicobacter pylori treatment failure. World J Gastroenterol (2008) 0.99
Second-line rescue therapy of helicobacter pylori infection. Therap Adv Gastroenterol (2009) 0.89
Levofloxacin-amoxicillin/clavulanate-rabeprazole versus a standard seven-day triple therapy for eradication of Helicobacter pylori infection. Biomed Res Int (2014) 0.86
Variability in Prevalence of Helicobacter pylori Strains Resistant to Clarithromycin and Levofloxacin in Southern Poland. Gastroenterol Res Pract (2012) 0.82
Ten-Day versus 14-Day Levofloxacin-Containing Triple Therapy for Second-Line Anti-Helicobacter pylori Eradication in Taiwan. Gastroenterol Res Pract (2013) 0.78
Research waste in diagnostic trials: a methods review evaluating the reporting of test-treatment interventions. BMC Med Res Methodol (2017) 0.77
The efficacy of moxifloxacin-based triple therapy in treatment of Helicobacter pylori infection: a systematic review and meta-analysis of randomized clinical trials. Braz J Med Biol Res (2013) 0.77
Systematic review: third-line susceptibility-guided treatment for Helicobacter pylori infection. Therap Adv Gastroenterol (2015) 0.76
Natural history of gallstone disease: Expectant management or active treatment? Results from a population-based cohort study. J Gastroenterol Hepatol (2010) 1.76
Incidence of gallstone disease in Italy: results from a multicenter, population-based Italian study (the MICOL project). World J Gastroenterol (2008) 1.31
Diverticular disease of the colon: new perspectives in symptom development and treatment. World J Gastroenterol (2003) 0.89
Analysis of genetic variability, antimicrobial susceptibility and virulence markers in Helicobacter pylori identified in Central Italy. Scand J Gastroenterol (2006) 0.87
Quadruple therapy with moxifloxacin and bismuth for first-line treatment of Helicobacter pylori. World J Gastroenterol (2012) 0.85
Helicobacter pylori isolates from proximal and distal stomach of patients never treated and already treated show genetic variability and discordant antibiotic resistance. Eur J Gastroenterol Hepatol (2011) 0.79
Premedication with tramadol in patients undergoing colonoscopy: a double-blind randomized placebo-controlled study. Dig Dis Sci (2004) 0.79
Use of hormone replacement therapy in Italian women aged 50-70 years. Maturitas (2004) 0.77